Sanofi
4,676.10
-13.10(-0.28%)
Market Cap₹10,799.50 Cr
PE Ratio27.17
IndustryHealthcare
Company Performance:
1D-0.28%
1M-7.43%
6M-24.84%
1Y-32.00%
5Y-45.98%
View Company Insightsright
More news about Sanofi
27Feb 25
Sanofi India Reports Mixed Q3 2024 Results with Revenue Growth and Profit Decline
Sanofi India Limited announced its Q3 2024 financial results, showing a 9.8% increase in revenue to ₹5,150 million, but a 33.8% decrease in net profit to ₹913 million. EBITDA grew by 18.5% to ₹1,180 million, with the EBITDA margin improving to 22.98%. Profit Before Tax increased by 14.8% to ₹1,140 million. An exceptional item of ₹80 million was noted, potentially impacting overall profit figures.
Sanofi
4,676.10
-13.10
(-0.28%)
1 Year Returns:-32.00%
Industry Peers
Sun Pharmaceutical
1,679.10
(+1.21%)
Divis Laboratories
6,621.50
(+0.32%)
Cipla
1,577.60
(+0.52%)
Torrent Pharmaceuticals
3,584.30
(+1.43%)
Dr Reddys Laboratories
1,255.90
(+1.27%)
Mankind Pharma
2,476.60
(+0.87%)
Zydus Life Science
987.65
(+0.31%)
Lupin
1,940.00
(-0.57%)
Alkem Laboratories
5,581.50
(+1.04%)
Aurobindo Pharma
1,101.00
(-0.48%)